GENEVA, SWITZERLAND--(Marketwired - Sep 14, 2015) - Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs for the targeted treatment of inflammatory diseases, immune-related disorders and cancer, proudly announces that it is a $150,000 Matching Sponsor of the Matthew and Andrew Akin Foundation "700 Miles to Hope" bicycle ride. Novimmune's donation will be used to provide financial aid to families that relocate to Cincinnati or other expert centers to receive treatment for Hemophagocytic Lymphohistiocytosis (HLH).
